Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALE
2026
DELISTED
Allete
ALE
| $5.22M | ﹤0.01% |
90,034
-7,113
| -7% | -$439K |
|
|
ASGI
2027
abrdn Global Infrastructure Income Fund
ASGI
$790M
| $5.22M | ﹤0.01% |
293,456
-4,227
| -1% | -$74.7K |
|
|
PROF
2028
Profound Medical
PROF
$241M
| $5.21M | ﹤0.01% |
400,680
-314
| -0.1% | -$3.9K |
|
2029
BondBloxx Bloomberg One Year Target Duration US Treasury ETF
XONE
$844M
| $5.2M | ﹤0.01% |
104,616
-1,150
| -1% | -$57.3K |
|
2030
CALL
Pinduoduo
PDD
$121B
| $5.19M | ﹤0.01% |
75,000
| – | – |
|
2031
CALL
Thor Industries
THO
$4.11B
| $5.17M | ﹤0.01% |
+50,000
| New | +$4.22M |
|
2032
Invesco Financial Preferred ETF
PGF
$668M
| $5.17M | ﹤0.01% |
360,538
-58,223
| -14% | -$840K |
|
2033
Axos Financial
AX
$5.8B
| $5.17M | ﹤0.01% |
131,039
+3,093
| +2% | +$120K |
|
2034
Plug Power
PLUG
$3.24B
| $5.16M | ﹤0.01% |
496,233
-33,949
| -6% | -$309K |
|
2035
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $5.16M | ﹤0.01% |
276,556
+35,544
| +15% | +$659K |
|
2036
InMode
INMD
$872M
| $5.13M | ﹤0.01% |
137,436
+1,577
| +1% | +$55.1K |
|
|
PDX
2037
PIMCO Dynamic Income Strategy Fund
PDX
$979M
| $5.13M | ﹤0.01% |
325,297
+10,746
| +3% | +$159K |
|
2038
Future Fuel
FF
$245M
| $5.1M | ﹤0.01% |
576,420
-13,629
| -2% | -$114K |
|
|
SCHW
2039
PUT
Charles Schwab
SCHW
$192B
| $5.1M | ﹤0.01% |
90,000
-4,200
| -4% | -$220K |
|
2040
Ingevity
NGVT
$2.64B
| $5.09M | ﹤0.01% |
87,597
-7,952
| -8% | -$477K |
|
2041
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
$1.11B
| $5.09M | ﹤0.01% |
81,837
-12,838
| -14% | -$739K |
|
2042
PUT
UBS Group
UBS
$176B
| $5.07M | ﹤0.01% |
+250,000
| New | +$5.03M |
|
2043
Wolfspeed
WOLF
$1.65B
| $5.07M | ﹤0.01% |
91,157
-21,533
| -19% | -$1.1M |
|
2044
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
| $5.06M | ﹤0.01% |
55,954
-1,031
| -2% | -$91K |
|
|
FYBR
2045
DELISTED
Frontier Communications
FYBR
| $5.06M | ﹤0.01% |
271,297
-13,900
| -5% | -$261K |
|
2046
AGF US Market Neutral Anti-Beta Fund
BTAL
$298M
| $5.04M | ﹤0.01% |
268,505
-4,031
| -1% | -$81.3K |
|
2047
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
| $5.02M | ﹤0.01% |
187,542
-44,185
| -19% | -$1.25M |
|
2048
AllianceBernstein
AB
$3.41B
| $5.02M | ﹤0.01% |
155,954
+12,765
| +9% | +$437K |
|
2049
VanEck Biotech ETF
BBH
$424M
| $5.01M | ﹤0.01% |
32,109
+601
| +2% | +$96K |
|
2050
KBR
KBR
$4.84B
| $5.01M | ﹤0.01% |
77,003
-8,052
| -9% | -$480K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.